JSPR

Jasper Therapeutics, Inc.

Healthcare · Biotechnology

$265.97 sample

-2.29 (-0.85%) 1D

Market cap

$570.8B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-04

Alerts

8

Price$265.97 +1.71% 3M daily closessample

269.21256.75

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 05INSInsider buy: Chief Executive Officer
Sep 24INSInsider buy: General Counsel
Sep 21INSInsider sell: General Counsel
Sep 10INSInsider buy: Chief Financial Officer
Sep 04SEC8-K filed: material event
Aug 31INSInsider buy: General Counsel
Aug 25SECDEF 14A filed
Aug 18SECDEF 14A filed

Sign up to see the real JSPR record →

Company facts

SEC EDGAR registration

Name: Jasper Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -31sample, -100 to +100
Reporting currency: USD

Who is positioning in JSPR

sample

Insiders: 32 insider transactions over 90 days, net selling, $630.3M
Congress: No member trades over 90 days
Institutions · 13F: 12 funds hold $8.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$25.7B +16.2% y/y

Q4 2024Q3 2026

Inventory$15.9B +15.8% y/y

Q4 2024Q3 2026

Accounts receivable$11.5B +8.2% y/y

Q4 2024Q3 2026

Total debt$32.3B +16.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $485.6B +9.0% 3M
Sample peer B: $305.1B +7.0% 3M
Sample peer C: $62.5B -4.8% 3M
Sample peer D: $526.5B -3.0% 3M
Sample peer E: $528.7B +6.3% 3M